• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例复发缓解型多发性硬化患者发生富马酸二甲酯诱发的应激性心肌病

Dimethyl Fumarate-Induced Takotsubo Cardiomyopathy in a Patient With Relapsing-Remitting Multiple Sclerosis.

作者信息

Srichawla Bahadar S

机构信息

Neurology, University of Massachusetts Chan Medical School, Worcester, USA.

出版信息

Cureus. 2022 Apr 3;14(4):e23789. doi: 10.7759/cureus.23789. eCollection 2022 Apr.

DOI:10.7759/cureus.23789
PMID:35518534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9067331/
Abstract

Dimethyl fumarate (DMF) is an approved oral pharmacologic agent used in the treatment of relapsing-remitting multiple sclerosis (RRMS). Although commonly used in clinical practice, its mechanism of action remains largely unknown. Some frequent side effects associated with this drug are angioedema, hepatic injury, flushing, herpes zoster infection, and abdominal pain among others. A 47-year-old female presented with symptoms of an allergic reaction after initiating DMF therapy. She required intensive care unit admission due to an acute-hypoxic respiratory failure. A transthoracic echocardiogram (TTE) revealed apical ballooning and a left ventricular ejection fraction (LVEF) of 35%-40%. A coronary angiogram revealed no coronary artery disease. The diagnosis of takotsubo cardiomyopathy was made. The patient was managed with high-dose steroids and an epinephrine drip, in addition to a high-flow nasal cannula (HFNC) for respiratory support. At a three-month follow-up, a repeat TTE showed a resolution of the underlying takotsubo cardiomyopathy (CM) with no stunted myocardium and a normal ejection fraction (EF). Here, I highlight a life-threatening case of DMF-induced takotsubo CM and familiarize clinicians and patients with the need for close monitoring of symptoms when initiating disease-modifying drug (DMD) therapy.

摘要

富马酸二甲酯(DMF)是一种已获批准的口服药物,用于治疗复发缓解型多发性硬化症(RRMS)。尽管在临床实践中常用,但其作用机制仍 largely 未知。与该药物相关的一些常见副作用包括血管性水肿、肝损伤、潮红、带状疱疹感染和腹痛等。一名47岁女性在开始 DMF 治疗后出现过敏反应症状。由于急性低氧性呼吸衰竭,她需要入住重症监护病房。经胸超声心动图(TTE)显示心尖部气球样变,左心室射血分数(LVEF)为35%-40%。冠状动脉造影显示无冠状动脉疾病。诊断为应激性心肌病。除了使用高流量鼻导管(HFNC)进行呼吸支持外,患者还接受了大剂量类固醇和肾上腺素滴注治疗。在三个月的随访中,重复 TTE 显示潜在的应激性心肌病(CM)得到缓解,心肌无发育不良,射血分数(EF)正常。在此,我强调一例 DMF 诱导的应激性 CM 的危及生命病例,并使临床医生和患者了解在开始疾病修正药物(DMD)治疗时密切监测症状的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dfa/9067331/160101ef3538/cureus-0014-00000023789-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dfa/9067331/160101ef3538/cureus-0014-00000023789-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dfa/9067331/160101ef3538/cureus-0014-00000023789-i01.jpg

相似文献

1
Dimethyl Fumarate-Induced Takotsubo Cardiomyopathy in a Patient With Relapsing-Remitting Multiple Sclerosis.一例复发缓解型多发性硬化患者发生富马酸二甲酯诱发的应激性心肌病
Cureus. 2022 Apr 3;14(4):e23789. doi: 10.7759/cureus.23789. eCollection 2022 Apr.
2
Zumba-induced Takotsubo cardiomyopathy: a case report.尊巴引发的应激性心肌病:一例报告
J Med Case Rep. 2018 Jun 10;12(1):160. doi: 10.1186/s13256-018-1696-x.
3
When a Tooth Pulls the Heart Strings: Takotsubo Cardiomyopathy Post-dental Extraction.当牙齿牵动心弦:拔牙后应激性心肌病
Cureus. 2023 Jul 17;15(7):e42044. doi: 10.7759/cureus.42044. eCollection 2023 Jul.
4
Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM.缓释富马酸二甲酯用于既往使用干扰素的复发缓解型多发性硬化症患者的疗效和安全性:DEFINE和CONFIRM的综合分析
Clin Ther. 2017 Aug;39(8):1671-1679. doi: 10.1016/j.clinthera.2017.06.012. Epub 2017 Jul 25.
5
Cost-utility of fingolimod compared with dimethyl fumarate in highly active relapsing-remitting multiple sclerosis (RRMS) in England.在英国高度活跃的复发缓解型多发性硬化症(RRMS)中,芬戈莫德与富马酸二甲酯相比的成本效益。
J Med Econ. 2015;18(11):874-85. doi: 10.3111/13696998.2015.1056794. Epub 2015 Jul 1.
6
Intraventricular thrombus and severe mitral regurgitation in the acute phase of takotsubo cardiomyopathy: two case reports.应激性心肌病急性期的脑室内血栓形成与严重二尖瓣反流:两例报告
J Med Case Rep. 2019 May 19;13(1):152. doi: 10.1186/s13256-019-2081-0.
7
72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension.在复发缓解型多发性硬化症的日本患者中,二甲基富马酸的 72 周安全性和耐受性:随机、双盲、安慰剂对照、III 期 APEX 研究及其开放标签扩展的分析。
Adv Ther. 2018 Oct;35(10):1598-1611. doi: 10.1007/s12325-018-0788-8. Epub 2018 Sep 11.
8
Biventricular takotsubo cardiomyopathy: case study and review of literature.双心室应激性心肌病:病例报告及文献综述
Tex Heart Inst J. 2013;40(3):305-11.
9
Regadenoson Cardiac Stress Test-Induced Takotsubo Cardiomyopathy: A Case Report.腺苷负荷心脏应激试验诱发的Takotsubo心肌病:一例报告
Cureus. 2020 May 7;12(5):e8004. doi: 10.7759/cureus.8004.
10
Atypical Takotsubo Cardiomyopathy with Hypokinetic Left Mid-ventricle and Apical Wall Sparing: A Case Report and Literature Review.左心室中部运动减弱及心尖部心肌 spared 的非典型 Takotsubo 心肌病:一例报告及文献综述
Curr Cardiol Rev. 2020;16(3):241-246. doi: 10.2174/1573403X15666191120114442.

引用本文的文献

1
The Immunology of Takotsubo Syndrome.Takotsubo 综合征的免疫学。
Front Immunol. 2023 Oct 6;14:1254011. doi: 10.3389/fimmu.2023.1254011. eCollection 2023.
2
Case Report: Steroid-Responsive Takotsubo Cardiomyopathy Associated With Cytokine Storm and Obstructive Shock.病例报告:与细胞因子风暴和梗阻性休克相关的类固醇反应性应激性心肌病
Front Cardiovasc Med. 2022 Jul 11;9:931070. doi: 10.3389/fcvm.2022.931070. eCollection 2022.

本文引用的文献

1
Immunological Predictors of Dimethyl Fumarate-Induced Lymphopenia.富马酸二甲酯诱导淋巴细胞减少的免疫预测指标
Ann Neurol. 2022 May;91(5):676-681. doi: 10.1002/ana.26328. Epub 2022 Mar 4.
2
COVID-19-related severe MS exacerbation with life-threatening Takotsubo cardiomyopathy in a previously stable patient and interference of MS therapy with long-term immunity against SARS-CoV-2.一名既往病情稳定的患者出现与 COVID-19 相关的严重多发性硬化症加重,并伴有危及生命的应激性心肌病,以及多发性硬化症治疗对针对 SARS-CoV-2 的长期免疫力的干扰。
J Neurol. 2022 Mar;269(3):1138-1141. doi: 10.1007/s00415-021-10779-0. Epub 2021 Oct 7.
3
[Relapsing-Remitting Multiple Sclerosis].
复发缓解型多发性硬化症
Brain Nerve. 2021 May;73(5):442-449. doi: 10.11477/mf.1416201784.
4
Cryptococcal meningitis in a patient with multiple sclerosis on dimethyl fumarate treatment: A case report.二羟苯丙氨酸(Dimethyl fumarate)治疗多发性硬化症患者合并隐球菌性脑膜炎:一例报告。
Mult Scler Relat Disord. 2020 Jul;42:102137. doi: 10.1016/j.msard.2020.102137. Epub 2020 Apr 29.
5
Takotsubo Cardiomyopathy: A Brief Review.应激性心肌病:简要综述
J Med Life. 2020 Jan-Mar;13(1):3-7. doi: 10.25122/jml-2018-0067.
6
Dimethyl Fumarate: A Review in Relapsing-Remitting MS.富马酸二甲酯:复发性缓解型多发性硬化症的综述。
Drugs. 2019 Dec;79(18):1965-1976. doi: 10.1007/s40265-019-01229-3.
7
Adherence to Disease-Modifying Therapies at a Multiple Sclerosis Clinic: The Role of the Specialty Pharmacist.多发性硬化症诊所中对疾病修正疗法的依从性:专科药剂师的作用。
J Pharm Pract. 2020 Oct;33(5):605-611. doi: 10.1177/0897190018824821. Epub 2019 Jan 30.
8
A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future.多发性硬化症的治疗方法综述:现状与未来。
Inflamm Res. 2019 Jan;68(1):25-38. doi: 10.1007/s00011-018-1185-0. Epub 2018 Sep 3.
9
First-line therapy in relapsing remitting multiple sclerosis.复发缓解型多发性硬化的一线治疗。
Rev Neurol (Paris). 2018 Jun;174(6):419-428. doi: 10.1016/j.neurol.2018.03.012. Epub 2018 Apr 25.
10
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.富马酸二甲酯通过靶向 GAPDH 和有氧糖酵解来调节免疫。
Science. 2018 Apr 27;360(6387):449-453. doi: 10.1126/science.aan4665. Epub 2018 Mar 29.